T1	Intervention 300 698	Cost analysis was performed from a societal perspective alongside a prospective, randomised, double-blinded, multicentre trial. One hundred and fifty patients with documented AF were randomly assigned to undergo cardiac surgery with or without AS. One hundred and thirty-two patients were included in the cost-effectiveness study. All costs (medical and non-medical) were measured during follow-up.
T2	Intervention 699 806	Costs data were combined with quality adjusted life years (QALYs) to obtain the incremental costs per QALY.
